Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01617
|
|||||
| Drug Name |
Primovist
|
|||||
| Synonyms |
Eovist; Primovist; gadoxate disodium; AC1L9OPS; gadolinium ethoxybenzyl-DTPA; MOLI000482; 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid; gadolinium(3+)
|
|||||
| Indication | Lung cancer [ICD11: 2C25] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H33GdN3O11+3
|
|||||
| Canonical SMILES |
CCOC1=CC=C(C=C1)CC(CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O.[Gd+3]
|
|||||
| InChI |
InChI=1S/C23H33N3O11.Gd/c1-2-37-18-5-3-16(4-6-18)9-17(26(14-22(33)34)15-23(35)36)10-24(11-19(27)28)7-8-25(12-20(29)30)13-21(31)32;/h3-6,17H,2,7-15H2,1H3,(H,27,28)(H,29,30)(H,31,32)(H,33,34)(H,35,36);/q;+3
|
|||||
| InChIKey |
PCZHWPSNPWAQNF-UHFFFAOYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 684.8 | Topological Polar Surface Area | 205 | ||
| Heavy Atom Count | 38 | Rotatable Bond Count | 20 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 14 | |||
| PubChem CID | ||||||
| DT(s) Transporting This Drug | OATP1B1 | Transporter Info | Organic anion transporting polypeptide 1B1 | Substrate | [2] | |
| OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [3] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03215355) Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium | |||||
| 2 | Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81. | |||||
| 3 | Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos. 2010 Jul;38(7):1024-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.